1. Home
  2. EDSA vs HCAI Comparison

EDSA vs HCAI Comparison

Compare EDSA & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • HCAI
  • Stock Information
  • Founded
  • EDSA 2015
  • HCAI 2004
  • Country
  • EDSA Canada
  • HCAI China
  • Employees
  • EDSA N/A
  • HCAI N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • HCAI Miscellaneous manufacturing industries
  • Sector
  • EDSA Health Care
  • HCAI Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • HCAI Nasdaq
  • Market Cap
  • EDSA 18.6M
  • HCAI 20.3M
  • IPO Year
  • EDSA N/A
  • HCAI 2025
  • Fundamental
  • Price
  • EDSA $1.73
  • HCAI $0.50
  • Analyst Decision
  • EDSA Strong Buy
  • HCAI
  • Analyst Count
  • EDSA 2
  • HCAI 0
  • Target Price
  • EDSA $13.00
  • HCAI N/A
  • AVG Volume (30 Days)
  • EDSA 908.6K
  • HCAI 55.5K
  • Earning Date
  • EDSA 12-12-2025
  • HCAI 12-19-2025
  • Dividend Yield
  • EDSA N/A
  • HCAI N/A
  • EPS Growth
  • EDSA N/A
  • HCAI N/A
  • EPS
  • EDSA N/A
  • HCAI 0.00
  • Revenue
  • EDSA N/A
  • HCAI $19,176,987.00
  • Revenue This Year
  • EDSA N/A
  • HCAI N/A
  • Revenue Next Year
  • EDSA N/A
  • HCAI N/A
  • P/E Ratio
  • EDSA N/A
  • HCAI $141.56
  • Revenue Growth
  • EDSA N/A
  • HCAI N/A
  • 52 Week Low
  • EDSA $1.55
  • HCAI $0.47
  • 52 Week High
  • EDSA $4.49
  • HCAI $10.97
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.70
  • HCAI 37.15
  • Support Level
  • EDSA $1.69
  • HCAI $0.50
  • Resistance Level
  • EDSA $1.83
  • HCAI $0.58
  • Average True Range (ATR)
  • EDSA 0.15
  • HCAI 0.05
  • MACD
  • EDSA -0.01
  • HCAI -0.00
  • Stochastic Oscillator
  • EDSA 17.00
  • HCAI 17.51

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

Share on Social Networks: